Literature DB >> 26318022

The Global Alzheimer's Association Interactive Network.

Arthur W Toga1, Scott C Neu2, Priya Bhatt2, Karen L Crawford2, Naveen Ashish2.   

Abstract

INTRODUCTION: The Global Alzheimer's Association Interactive Network (GAAIN) is consolidating the efforts of independent Alzheimer's disease data repositories around the world with the goals of revealing more insights into the causes of Alzheimer's disease, improving treatments, and designing preventative measures that delay the onset of physical symptoms.
METHODS: We developed a system for federating these repositories that is reliant on the tenets that (1) its participants require incentives to join, (2) joining the network is not disruptive to existing repository systems, and (3) the data ownership rights of its members are protected.
RESULTS: We are currently in various phases of recruitment with over 55 data repositories in North America, Europe, Asia, and Australia and can presently query >250,000 subjects using GAAIN's search interfaces. DISCUSSION: GAAIN's data sharing philosophy, which guided our architectural choices, is conducive to motivating membership in a voluntary data sharing network.
Copyright © 2016 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Data sharing; Federated data repositories; GAAIN

Mesh:

Year:  2015        PMID: 26318022      PMCID: PMC4817494          DOI: 10.1016/j.jalz.2015.06.1896

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  19 in total

Review 1.  Opinion: Sharing primary data: a threat or asset to discovery?

Authors:  Stephen H Koslow
Journal:  Nat Rev Neurosci       Date:  2002-04       Impact factor: 34.870

Review 2.  A debate over fMRI data sharing.

Authors: 
Journal:  Nat Neurosci       Date:  2000-09       Impact factor: 24.884

Review 3.  The Alzheimer's disease neuroimaging initiative: progress report and future plans.

Authors:  Michael W Weiner; Paul S Aisen; Clifford R Jack; William J Jagust; John Q Trojanowski; Leslie Shaw; Andrew J Saykin; John C Morris; Nigel Cairns; Laurel A Beckett; Arthur Toga; Robert Green; Sarah Walter; Holly Soares; Peter Snyder; Eric Siemers; William Potter; Patricia E Cole; Mark Schmidt
Journal:  Alzheimers Dement       Date:  2010-05       Impact factor: 21.566

4.  Mandatory submission of microarray data to public repositories: how is it working?

Authors:  Beverly Ventura
Journal:  Physiol Genomics       Date:  2005-01-20       Impact factor: 3.107

5.  CDISC standard-based electronic archiving of clinical trials.

Authors:  Wolfgang Kuchinke; J Aerts; S C Semler; C Ohmann
Journal:  Methods Inf Med       Date:  2009-07-20       Impact factor: 2.176

6.  Big data: could it ever cure Alzheimer's disease?

Authors:  Masud Husain
Journal:  Brain       Date:  2014-10       Impact factor: 13.501

7.  Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia.

Authors:  J A Kaye; T Swihart; D Howieson; A Dame; M M Moore; T Karnos; R Camicioli; M Ball; B Oken; G Sexton
Journal:  Neurology       Date:  1997-05       Impact factor: 9.910

8.  Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.

Authors:  Leslie M Shaw; Hugo Vanderstichele; Malgorzata Knapik-Czajka; Christopher M Clark; Paul S Aisen; Ronald C Petersen; Kaj Blennow; Holly Soares; Adam Simon; Piotr Lewczuk; Robert Dean; Eric Siemers; William Potter; Virginia M-Y Lee; John Q Trojanowski
Journal:  Ann Neurol       Date:  2009-04       Impact factor: 10.422

9.  MRI of hippocampal volume loss in early Alzheimer's disease in relation to ApoE genotype and biomarkers.

Authors:  N Schuff; N Woerner; L Boreta; T Kornfield; L M Shaw; J Q Trojanowski; P M Thompson; C R Jack; M W Weiner
Journal:  Brain       Date:  2009-02-27       Impact factor: 13.501

10.  Minimum Information About a Microarray Experiment (MIAME)--successes, failures, challenges.

Authors:  Alvis Brazma
Journal:  ScientificWorldJournal       Date:  2009-05-29
View more
  12 in total

1.  Item-Level Story Recall Predictors of Amyloid-Beta in Late Middle-Aged Adults at Increased Risk for Alzheimer's Disease.

Authors:  Kimberly D Mueller; Lianlian Du; Davide Bruno; Tobey Betthauser; Bradley Christian; Sterling Johnson; Bruce Hermann; Rebecca Langhough Koscik
Journal:  Front Psychol       Date:  2022-06-27

2.  Virtual Connectomic Datasets in Alzheimer's Disease and Aging Using Whole-Brain Network Dynamics Modelling.

Authors:  Lucas Arbabyazd; Kelly Shen; Zheng Wang; Martin Hofmann-Apitius; Petra Ritter; Anthony R McIntosh; Demian Battaglia; Viktor Jirsa
Journal:  eNeuro       Date:  2021-07-06

Review 3.  Big data sharing and analysis to advance research in post-traumatic epilepsy.

Authors:  Dominique Duncan; Paul Vespa; Asla Pitkänen; Adebayo Braimah; Niina Lapinlampi; Arthur W Toga
Journal:  Neurobiol Dis       Date:  2018-06-01       Impact factor: 5.996

Review 4.  The past, present, and future of disease-modifying therapies for Alzheimer's disease.

Authors:  Kazushi Suzuki; Atsushi Iwata; Takeshi Iwatsubo
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2017       Impact factor: 3.493

5.  The Association between the Usage of Non-Steroidal Anti-Inflammatory Drugs and Cognitive Status: Analysis of Longitudinal and Cross-Sectional Studies from the Global Alzheimer's Association Interactive Network and Transcriptomic Data.

Authors:  Robert Morris; Kyle Armbruster; Julianna Silva; Daniel James Widell; Feng Cheng
Journal:  Brain Sci       Date:  2020-12-10

Review 6.  The ARIC (Atherosclerosis Risk In Communities) Study: JACC Focus Seminar 3/8.

Authors:  Jacqueline D Wright; Aaron R Folsom; Josef Coresh; A Richey Sharrett; David Couper; Lynne E Wagenknecht; Thomas H Mosley; Christie M Ballantyne; Eric A Boerwinkle; Wayne D Rosamond; Gerardo Heiss
Journal:  J Am Coll Cardiol       Date:  2021-06-15       Impact factor: 27.203

Review 7.  What incentives increase data sharing in health and medical research? A systematic review.

Authors:  Anisa Rowhani-Farid; Michelle Allen; Adrian G Barnett
Journal:  Res Integr Peer Rev       Date:  2017-05-05

8.  Accelerating drug development for Alzheimer's disease through the use of data standards.

Authors:  Jon Neville; Steve Kopko; Klaus Romero; Brian Corrigan; Bob Stafford; Elizabeth LeRoy; Steve Broadbent; Martin Cisneroz; Ethan Wilson; Eric Reiman; Hugo Vanderstichele; Stephen P Arnerić; Diane Stephenson
Journal:  Alzheimers Dement (N Y)       Date:  2017-04-15

9.  The Association between Tau Protein Level in Cerebrospinal Fluid and Cognitive Status: A Large-Scale Analysis of GAAIN Database.

Authors:  Kyle Eckhoff; Robert Morris; Valeria Zuluaga; Rebecca Polsky; Feng Cheng
Journal:  Brain Sci       Date:  2021-06-29

Review 10.  Relationship Between Amyloid-β Deposition and Blood-Brain Barrier Dysfunction in Alzheimer's Disease.

Authors:  Dong Wang; Fanglian Chen; Zhaoli Han; Zhenyu Yin; Xintong Ge; Ping Lei
Journal:  Front Cell Neurosci       Date:  2021-07-19       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.